Wireless retinal implant helps blind patients see again
A 2×2 mm wireless subretinal photovoltaic implant restored meaningful central vision in more than 80% of participants in an international NEJM-published clinical trial for geographic atrophy due to age-related macular degeneration; many patients could read letters and words again as the device converts light into electrical signals replacing damaged photoreceptors.
Why it mattersNEJM trial for geographic atrophy (AMD) reported >80% regained meaningful central vision.